Horizon Pharma, Inc. (HZNP) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

75% of 4 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 09/18/2014 1 week $12.37 $12.37 no change 0 Active
Comments:
oldmonk7 oldmonk7 08/13/2014 3 months $9.93 $12.37 +24.57% 24 Active
Comments: good company and product
jrdelane jrdelane 06/27/2014 3 months $15.96 $12.37 -22.49% -22 Active
Comments: When close merger w Vidara, increases in revs, profitability
Oldpoot Oldpoot 05/08/2014 3 months $14.16 $8.85 -37.5% -37 Ended
Comments:
SR527 SR527 03/22/2014 1 Year $17.35 $12.37 -28.7% -28 Active
Comments: Brilliant business minds, an aggressive growth strategy and very good product line!!!!
Holstadt d Holbech Holstadt d Holbech 03/20/2014 3 months $16.02 $15.83 -1.19% -1 Ended
Comments: way undervalued by the market. 30% increase next two quarters.
Gold Treasure Gold Treasure 03/19/2014 3 months $16.69 $14.95 -10.43% -10 Ended
Comments: poised for growth
jubei jubei 11/12/2013 1 day $4.48 $4.56 +1.9% -1 Ended
Comments:
inBestment inBestment 10/22/2013 3 months $4.29 $8.61 +100.93% 100 Ended
Comments: Questions or Suggestions feel free to contact me Kreuz55@hotmail.com
JOKER66 JOKER66 11/13/2012 1 day $2.60 $2.30 -11.54% -11 Ended
Comments:
mYFuchar mYFuchar 10/10/2012 3 months $3.30 $3.85 +16.67% 16 Ended
Comments: 2 fda approved drugs, its under valued
Dermott Dermott 07/24/2012 1 week $7.56 $5.80 -23.28% -23 Ended
Comments: Watch for Covidien to purchase on 26th July or near future.
RandallFurne RandallFurne 06/29/2012 3 months $7.16 $3.47 -51.54% -51 Ended
Comments: Industry sector growing or poised for growth
joeymore joeymore 04/20/2012 3 months $3.84 $7.12 +85.42% 85 Ended
Comments: This stock is undervalued

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.